Liver and spleen volume variations in patients with hepatic fibrosis

Table 1 Comparison of related volumes in patients with liver fibrosis and healthy controls (mean ± SD)

Group	Patients (n)	Liver volume (cm3)	Standard liver volume (cm3)	Spleen volume (cm3)	Liver/spleen volume ratio	Standard liver/spleen volume ratio
Control	15	1133.39 ± 131.84	637.98 ± 65.93	190.94 ± 70.37bd	6.70 ± 2.56bd	3.81 ± 1.62bde
Stage 1	34	1117.33 ± 190.37	575.96 ± 73.82	213.20 ± 77.30bd	5.84 ± 2.05bd	3.05 ± 1.14ad
Stage 2	25	1158.30 ± 229.10	592.49 ± 65.31	253.53 ± 113.43bd	5.13 ± 1.55d	2.69 ± 0.96c
Stage 3	16	1168.23 ± 202.82	607.35 ± 69.81	358.67 ± 154.63	3.83 ± 1.77	2.00 ± 0.87
Stage 4	10	1126.40 ± 271.38	590.11 ± 114.70	479.65 ± 181.56	2.67 ± 1.12	1.39 ± 0.53
F value		0.245	1.902	12.383	9.702	9.784
P value		0.912	0.116	0.000	0.000	0.000

^aP < 0.05,

^bP < 0.01 vs S3;

^cP < 0.05,

^dP < 0.01 vs S4;

^eP < 0.05 vs S2.